Stay updated on Pembrolizumab in Poor-Prognosis CUP Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.

Latest updates to the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page
- CheckyesterdayChange DetectedAdded a dedicated 'Locations' section with Alberta and Ontario listings. Removed separate 'Alberta Locations' and 'Ontario Locations' references and updated the page footer to Revision: v3.3.3.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision v3.3.1 was added and Revision v3.2.0 was removed from the page.SummaryDifference0.1%

- Check36 days agoChange DetectedThe government funding status notice banner was removed from the page. The study details and page structure remain unchanged.SummaryDifference0.4%

- Check51 days agoChange DetectedEnrollment has been updated to 26 participants and the last update date is 2025-04-25. There are also minor textual revisions to sections such as eligibility criteria.SummaryDifference0.4%

- Check80 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Poor-Prognosis CUP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.